Oxford-based life sciences provider Amsbio has entered into a strategic commercial partnership with Newcastle-headquartered biotechnology innovator Atelerix to distribute a…
Read More
Amsbio Unveils StemFit Basic04CT to Streamline Human Pluripotent Stem Cell Culture from Research to Clinical Manufacturing
The global landscape of regenerative medicine and cell therapy manufacturing has reached a significant operational milestone with the official introduction…
Read More
AMSBIO Biospecimens Fuel Landmark Roche Study Uncovering Fibroblast Activation Protein’s Critical Role in Cancer Immunotherapy
A collaborative research effort, leveraging extensively characterized biospecimens provided by AMSBIO, has yielded groundbreaking insights into the multifaceted role of…
Read More
AMSBIO Launches Comprehensive Range of Authenticated Cell Lines to Combat Research Reproducibility Crisis
AMSBIO, a leading innovator in life sciences, has announced the launch of a new, extensive range of authenticated cell lines,…
Read More
AMSBIO Reports Karolinska Institutet’s Groundbreaking Research Using AAV Products to Uncover Neural Basis of Rheumatoid Arthritis Pain
AMSBIO, a leading provider of life science reagents and services, has announced its involvement in a pivotal research endeavor by…
Read More
AMSBIO Unveils Advanced Quick-Glia™ iPSC Differentiation Kits, Revolutionizing Neurobiology and Drug Discovery for Human Glial Cells
AMSBIO, a global leader in life sciences solutions, has significantly expanded its portfolio of induced pluripotent stem cell (iPSC) Differentiation…
Read MoreYOU MAY HAVE MISSED
